Key points are not available for this paper at this time.
Our global survey reveals no cases of insertional mutagenesis following CAR T-cells in pediatric patients challenging concerns of secondary malignancy risk in this population.This underscores the safety of CAR T-cell therapy in this population, but ongoing surveillance required.
Building similarity graph...
Analyzing shared references across papers
Loading...
Adam J. Lamble
Seattle Children's Hospital
Liora M. Schultz
Palo Alto University
Khanh Nguyen
Palo Alto University
Blood Advances
Stanford University
National Institutes of Health
University College London
Building similarity graph...
Analyzing shared references across papers
Loading...
Lamble et al. (Fri,) studied this question.
synapsesocial.com/papers/68e6b93cb6db64358763a658 — DOI: https://doi.org/10.1182/bloodadvances.2024013243